{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-085434","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2026-08-05T13:28:46+00:00","discovered_at":"2026-08-05T13:30:00.317737+00:00","generated_at":"2026-08-05T13:30:08.742035+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Citius Oncology reports 78% QoQ increase in new institutions ordering LYMPHIR; vials up 31%","bullets":["New institutional accounts ordering LYMPHIR increased 78% QoQ; total institutions now 42.","Vials ordered by institutions rose 31% during quarter ended June 30, 2026.","LYMPHIR has near-universal payer coverage; initial CTCL market exceeds $400M.","Company expects >20 additional institutions in current quarter, targeting 100 priority institutions by year-end.","Wholesaler orders have begun to reflect increased demand; revenue recognized on wholesale orders."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-085434","json":"https://secwatch.observer/filing/0001213900-26-085434.json","markdown":"https://secwatch.observer/filing/0001213900-26-085434.md","text":"https://secwatch.observer/filing/0001213900-26-085434.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390026085434/0001213900-26-085434-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390026085434/ea0300371-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T13:30:08.742035+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}